Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Post by pennyDoctoron Dec 30, 2015 11:24am
340 Views
Post# 24419233

Board appointment Parmar Resigns

Board appointment Parmar Resigns

Mr. Eugene Beukman reports

VANC PHARMACEUTICALS PROVIDES A CORPORATE UPDATE

Vanc Pharmaceuticals Inc.'s chief executive officer Arun Nayyar is joining the board as director with immediate effect. Aman Parmar has resigned as chief financial officer and director from the board. Vanc expresses thanks to Mr. Parmar for his services and wishes him the very best for his future. Rohit Prakash, who had joined in September as finance controller, will be managing the financial operations. Eugene Beukman, corporate secretary, will take on additional responsibility as CFO. The company has granted 400,000 stock options at 40 cents per option to employees and directors as per the regulatory guidelines.

Bullboard Posts